Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.8061 USD | -5.16% | +5.39% | -0.48% |
Financials (USD)
Sales 2024 * | 30.79M | Sales 2025 * | 11.82M | Capitalization | 79.76M |
---|---|---|---|---|---|
Net income 2024 * | -63M | Net income 2025 * | -84M | EV / Sales 2024 * | 2.59 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 6.75 x |
P/E ratio 2024 * |
-1.74
x | P/E ratio 2025 * |
-1.65
x | Employees | 165 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 78.46% |
Latest transcript on HOOKIPA Pharma Inc.
1 day | -5.16% | ||
1 week | +5.39% | ||
Current month | +13.22% | ||
1 month | +14.73% | ||
3 months | +13.54% | ||
6 months | +76.39% | ||
Current year | -0.48% |
Managers | Title | Age | Since |
---|---|---|---|
Jörn Aldag
CEO | Chief Executive Officer | 65 | 16-05-31 |
Reinhard Kandera
DFI | Director of Finance/CFO | 54 | 17-03-31 |
Klaus Orlinger
CTO | Chief Tech/Sci/R&D Officer | 46 | 12-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jörn Aldag
CEO | Chief Executive Officer | 65 | 16-05-31 |
Chairman | 63 | 17-09-30 | |
Reinhard Kandera
DFI | Director of Finance/CFO | 54 | 17-03-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 0.8061 | -5.16% | 1,847,514 |
24-04-24 | 0.85 | +11.11% | 10,443,832 |
24-04-23 | 0.765 | +8.20% | 791,938 |
24-04-22 | 0.707 | -3.55% | 872,297 |
24-04-19 | 0.733 | -4.17% | 443,545 |
Delayed Quote Nasdaq, April 25, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.48% | 84.11M | |
+24.17% | 562B | |
-6.33% | 358B | |
+19.90% | 322B | |
+7.95% | 297B | |
+13.45% | 219B | |
+6.04% | 199B | |
-10.51% | 196B | |
-12.26% | 149B | |
-6.47% | 146B |
- Stock Market
- Equities
- HOOK Stock